The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders

Christopher J. Hammond

doi:10.1016/j.chc.2016.05.004

The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders

Christopher J. Hammond

School of Medicine

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Adolescent substance use disorders (SUDs) are a significant public health issue due to the associated morbidity, mortality, and societal cost. While effective for some adolescents, psychosocial interventions generally produce small-to-moderate reductions in substance use. Most youth relapse within 12 months of treatment. One approach to improve outcomes is through adjunctive pharmacotherapy. Medication assisted treatments have been shown to improve adult SUD treatment outcomes, and preliminary studies in adolescents suggest that combining medication with psychosocial interventions may also enhance SUD outcomes for youth. This article presents a comprehensive review and grading of the evidence from studies conducted in adolescents with SUDs.

Original language	English (US)
Pages (from-to)	685-711
Number of pages	27
Journal	Child and Adolescent Psychiatric Clinics of North America
Volume	25
Issue number	4
DOIs	https://doi.org/10.1016/j.chc.2016.05.004
State	Published - Oct 1 2016

Keywords

Addiction
Adolescence
Development
Medication
Pharmacotherapy
Substance use disorder

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Psychiatry and Mental health

Access to Document

10.1016/j.chc.2016.05.004

Cite this

@article{700864b4e3294578b3324ec8ee988b98,

title = "The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders",

abstract = "Adolescent substance use disorders (SUDs) are a significant public health issue due to the associated morbidity, mortality, and societal cost. While effective for some adolescents, psychosocial interventions generally produce small-to-moderate reductions in substance use. Most youth relapse within 12 months of treatment. One approach to improve outcomes is through adjunctive pharmacotherapy. Medication assisted treatments have been shown to improve adult SUD treatment outcomes, and preliminary studies in adolescents suggest that combining medication with psychosocial interventions may also enhance SUD outcomes for youth. This article presents a comprehensive review and grading of the evidence from studies conducted in adolescents with SUDs.",

keywords = "Addiction, Adolescence, Development, Medication, Pharmacotherapy, Substance use disorder",

author = "Hammond, {Christopher J.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.chc.2016.05.004",

language = "English (US)",

volume = "25",

pages = "685--711",

journal = "Child and Adolescent Psychiatric Clinics of North America",

issn = "1056-4993",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders

AU - Hammond, Christopher J.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Adolescent substance use disorders (SUDs) are a significant public health issue due to the associated morbidity, mortality, and societal cost. While effective for some adolescents, psychosocial interventions generally produce small-to-moderate reductions in substance use. Most youth relapse within 12 months of treatment. One approach to improve outcomes is through adjunctive pharmacotherapy. Medication assisted treatments have been shown to improve adult SUD treatment outcomes, and preliminary studies in adolescents suggest that combining medication with psychosocial interventions may also enhance SUD outcomes for youth. This article presents a comprehensive review and grading of the evidence from studies conducted in adolescents with SUDs.

AB - Adolescent substance use disorders (SUDs) are a significant public health issue due to the associated morbidity, mortality, and societal cost. While effective for some adolescents, psychosocial interventions generally produce small-to-moderate reductions in substance use. Most youth relapse within 12 months of treatment. One approach to improve outcomes is through adjunctive pharmacotherapy. Medication assisted treatments have been shown to improve adult SUD treatment outcomes, and preliminary studies in adolescents suggest that combining medication with psychosocial interventions may also enhance SUD outcomes for youth. This article presents a comprehensive review and grading of the evidence from studies conducted in adolescents with SUDs.

KW - Addiction

KW - Adolescence

KW - Development

KW - Medication

KW - Pharmacotherapy

KW - Substance use disorder

UR - http://www.scopus.com/inward/record.url?scp=84996549885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996549885&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2016.05.004

DO - 10.1016/j.chc.2016.05.004

M3 - Review article

C2 - 27613346

AN - SCOPUS:84996549885

SN - 1056-4993

VL - 25

SP - 685

EP - 711

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

IS - 4

ER -

The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this